COMPASS HOUSE MEDICAL CENTRES — All Prescriptions & Medications
Practice Code: L83055 | BRIXHAM, TQ5 9TF
Over the last 12 months, COMPASS HOUSE MEDICAL CENTRES prescribed 377,974 items across 727 different medications at a total cost of £2,933,854 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ketotifen fumarate | 10 | 600 | £138 | +14.9% ▲ |
| Almotriptan | 10 | 114 | £245 | -19.3% ▼ |
| Metronidazole | 10 | 400 | £41 | +51.2% ▲ |
| Tamsulosin and dutasteride hydrochloride | 10 | 600 | £276 | -71.4% ▼ |
| Duloxetine hydrochloride | 10 | 294 | £72 | -80.5% ▼ |
| Magnesium citrate | 10 | 1,620 | £477 | +38.3% ▲ |
| Riboflavin | 10 | 1,120 | £200 | +8.2% ▲ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 10 | 59.0K | £655 | -46.6% ▼ |
| Atropine sulfate | 10 | 300 | £344 | -21.5% ▼ |
| Cocois | 10 | 920 | £147 | -27.2% ▼ |
| 10 | 115 | £156 | -66.5% ▼ | |
| 10 | 24 | £363 | -1.5% vs avg | |
| 10 | 60 | £168 | +38.0% ▲ | |
| 10 | 300 | £957 | -12.2% ▼ | |
| 10 | 900 | £2.9K | +7.1% ▲ | |
| 10 | 450 | £930 | -34.4% ▼ | |
| 10 | 304 | £404 | -21.5% ▼ | |
| Nizatidine | 11 | 616 | £1.4K | -68.0% ▼ |
| Rabeprazole sodium | 11 | 700 | £85 | -78.7% ▼ |
| Phosphates (Rectal) | 11 | 146 | £503 | -10.0% ▼ |
| Omega-3-acid ethyl esters | 11 | 1,232 | £595 | -47.9% ▼ |
| Umeclidinium bromide | 11 | 11 | £288 | -82.2% ▼ |
| Daridorexant | 11 | 330 | £439 | -15.8% ▼ |
| Valproic acid | 11 | 1,320 | £309 | -24.8% ▼ |
| Phenobarbital | 11 | 1,288 | £208 | -64.2% ▼ |
| Relugolix | 11 | 386 | £1.1K | +279.8% ▲ |
| RtS 2 kcal/ml m/sk high protein, high energy+fibre (0913011) | 11 | 46.2K | £561 | -7.7% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 11 | 570 | £32 | -26.8% ▼ |
| Loteprednol etabonate | 11 | 65 | £68 | +18.9% ▲ |
| Nepafenac | 11 | 55 | £156 | +77.1% ▲ |
| 11 | 105 | £355 | +74.9% ▲ | |
| 11 | 97 | £281 | +2.6% ▲ | |
| 11 | 803 | £107 | -95.0% ▼ | |
| 11 | 22 | £406 | -15.9% ▼ | |
| 11 | 1,260 | £916 | +52.1% ▲ | |
| 11 | 780 | £2.8K | -54.8% ▼ | |
| 11 | 450 | £1.6K | -23.1% ▼ | |
| 11 | 600 | £3.0K | -5.3% ▼ | |
| 11 | 320 | £1.6K | +16.5% ▲ | |
| 11 | 330 | £695 | +19.5% ▲ | |
| Sodium cromoglicate | 12 | 2,400 | £3.6K | +16.0% ▲ |
| Linaclotide | 12 | 336 | £428 | -34.3% ▼ |
| Nadolol | 12 | 644 | £425 | +18.7% ▲ |
| Olmesartan medoxomil/amlodipine | 12 | 672 | £387 | -9.0% ▼ |
| Ciclesonide | 12 | 19 | £670 | -18.5% ▼ |
| Sulpiride | 12 | 672 | £56 | -55.2% ▼ |
| Saxagliptin | 12 | 336 | £360 | -64.1% ▼ |
| Dapagliflozin/metformin | 12 | 672 | £417 | -72.7% ▼ |
| Estradiol valerate | 12 | 980 | £82 | -38.6% ▼ |
| Sodium feredetate | 12 | 5,120 | £146 | -58.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.